REPROCELL
Nikola Kolundzic, Ph.D. has a diverse work experience spanning various roles and industries. Starting in 2012, they worked as an Education Writer & Illustrator for New School a.k.a. Nova Škola. In 2015, they transitioned to being a Freelance Graphic Designer for 99 Designs. From 2016 to 2017, they served as a Research Project Coordinator at POLYHEDRA d.o.o. They then joined the Institute for the Application of Nuclear Energy - INEP as a Research Associate from 2007 to 2017. In 2017, they became a Postdoctoral Research Associate at King's College London, where they worked until 2021. During this time, they also worked as a Science Consultant & Biomedical Communicator at Graphite from 2020 to 2021. In 2016, they started working as a Scientific & Medical Illustrator at Upwork, a role they still hold. Lastly, in 2019, they founded Kold Design, offering custom-made visual stories across science, education, technology, and healthcare. They have extensive experience in scientific, medical, and technical illustration, utilizing various graphic design tools.
Nikola Kolundzic, Ph.D. received their Bachelor's Degree in Biology from the University of Belgrade, where they studied from 2001 to 2006. Nikola then pursued a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology at the University of Belgrade from 2007 to 2012. In addition, they have obtained several certifications in graphic design and illustration, including the Upwork Skill Certification in Illustration from Upwork in September 2020, and various Coursera Course Certificates from the California Institute of the Arts in 2018. Nikola Kolundzic has also completed a course on natural history illustration from edX in April 2020.
This person is not in any offices
REPROCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES/ iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation. On February 10, 2014, it established a Kanagawa-based wholly owned subsidiary. On June 30, 2014, it acquired 85.2% interests in Reinnervate Limited, a UK-based company. On July 1, 2014, it fully acquired Reinnervate Limited. In July, 2014, it acquired BioServe Biotechnologies, Ltd. On September 2, 2014, it completed the acquisition of BioServe Biotechnologies, Ltd.